Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice

Amino Acids

Volumn 42, Issue 6, 2012, Pages 2411-2416

  Peters, Verena ^a   Schmitt, Claus P ^a   Zschocke, Johannes ^b   Gross, Marie Luise ^c   Brismar, Kerstin ^d   Forsberg, Elisabete ^d  

^a Centre for Pediatric and Adolescent Medicine   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Institute of Pathology   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anserine; Carnosinase (CN1); Carnosine; Diabetic mice (db db); Vascular permeability

Indexed keywords

ANSERINE; CARNOSINASE 1; CARNOSINE; HOMOCARNOSINE; KIDNEY ENZYME; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME METABOLISM; KIDNEY METABOLISM; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; TISSUE DISTRIBUTION; TISSUE LEVEL; TREATMENT DURATION;

AGE FACTORS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANSERINE; CAPILLARY PERMEABILITY; CARNOSINE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIPEPTIDASES; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; MICE; PROTEINURIA;

MUS;

EID: 84862755958     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1046-4     Document Type: Article

References (30)

1. G Aldini RM Facino G Beretta M Carini 2005 Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives Biofactors 24 77 87 16403966 10.1002/biof.5520240109 1:CAS:528:DC%2BD2MXht1GjtrfE
2. M Alhamdani HF Al-Azzawie FK Abbas 2005 Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides Perit Dial Int 27 86 89
3. S Aydogan H Yapislar S Artis B Aydogan 2008 Impaired erythrocytes deformability in H(2)O(2)-induced oxidative stress: protective effect of L-carnosine Clin Hemorheol Microcirc 39 93 98 18503115 1:CAS:528: DC%2BD1cXlvFSjtrY%3D
4. MH Baslow 2010 A novel key-lock mechanism for inactivating amino acid neuro-transmitters during transit across extracellular space Amino Acids 38 51 55 19151913 10.1007/s00726-009-0232-0 1:CAS:528:DC%2BC3cXhtVehtbw%3D
5. D Bates 2010 Vascular endothelial growth factors and vascular permeability Cardiovascular Res 87 262 271 10.1093/cvr/cvq105 1:CAS:528:DC%2BC3cXotlCht7s%3D
6. AA Boldyrev 1993 Does carnosine possess direct antioxidant activity? Int J Biochem 25 1101 1107 8405650 10.1016/0020-711X(93)90587-5 1:CAS:528: DyaK3sXlvFGjs7o%3D
7. AA Boldyrev SE Severin 1990 The histidine-containing dipeptides, carnosine and anserine: distribution, properties and biological significance Adv Enzyme Regul 30 175 194 2206021 10.1016/0065-2571(90)90017-V 1:CAS:528:DyaK3cXlvVKlsLY%3D
8. A Boldyrev E Bulygina T Leinsoo I Petrushanko S Tsubone H Abe 2004 Protection of neuronal cells against reactive oxygen species by carnosine and related compounds Comp Biochem Physiol B Biochem Mol Biol 137 81 88 14698913 10.1016/j.cbpc.2003.10.008
9. A Hipkiss 2010 Aging, proteotoxicity, mitochondria, glycation, nad and carnosine: possible inter-relationships and Resolution of the Oxygen Paradox Front Aging Neurosci 2 10 20552048 1:CAS:528:DC%2BC3MXpt1Gku7Y%3D
10. W Hou HJ Chen YH Lin 2003 Antioxidant peptides with angiotensin converting enzyme inhibitory activities and applications for Angiotensin converting enzyme purification J Agric Food Chem 51 1706 1709 12617609 10.1021/jf0260242 1:CAS:528:DC%2BD3sXhtVOjurg%3D
11. J Ibla J Khoury 2006 Methods to assess tissue permeability Methods Mol Biol 341 111 117 16799193
12. EE Jansen KM Gibson Y Shigematsu C Jakobs NM Verhoeven 2006 A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatography-tandem mass spectrometry J Chromatogr B Anal Technol Biomed Life Sci 830 196 200 10.1016/j.jchromb.2005.10.053 1:CAS:528:DC%2BD28XksVClsg%3D%3D
13. B Janssen D Hohenadel P Brinkkoetter, et al. 2005 Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1 Diabetes 54 2320 2327 16046297 10.2337/diabetes.54.8. 2320 1:CAS:528:DC%2BD2MXnt1ynsbc%3D
14. J Kang KS Kim SY Choi HY Kwon MH Won TC Kang 2002 Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu, Zn-superoxide dismutase modification Biochim Biophys Acta 1570 89 96 11985892 10.1016/S0304-4165(02)00158-7 1:CAS:528:DC%2BD38Xjtl2ksbk%3D
15. D Kubomura Y Matahira K Nagai A Jijima 2010 Effect of anserine ingestion on hyperglycemia and the autonomic nerves in rats and humans Nutr Neurosci 13 183 188 20670474 10.1179/147683010X12611460764363 1:CAS:528:DC%2BC3cXhsVSqs73J
16. K Lee SR Kim SJ Park, et al. 2006 Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor Am J Respir Cell Mol Biol 35 161 170
17. C Matthew IV Sils AM Bastille 2002 Tissue-specific extravasation of albumin-bound Evans blue in hypothermic and rewarmed rats Can J Physiol Pharmacol 80 233 243 11991235 10.1139/y02-044 1:CAS:528:DC%2BD38XivFGlsrs%3D
18. I McManus 1962 Enzymatic synthesis if anserine in skeletal muscle by N-methylation of carnosine J Biol Chem 237 1207 1211 1:CAS:528:DyaF3sXpsl2j
19. J Min MC Senut K Rajanikant, et al. 2008 Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia J Neurosci Res 86 2984 2991 18543335 10.1002/jnr.21744 1:CAS:528:DC%2BD1cXht1Gmtb7P
20. M Mozdan J Szemraj J Rysz D Nowak 2005 Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions Basic Clin Pharmacol Toxicol 96 352 360 10.1111/j.1742-7843.2005.pto-03.x
21. V Peters M Kebbewar EW Jansen, et al. 2010 Relevance of allosteric conformations and homocarnosine concentration on carnosinase activity Amino Acids 38 1607 1615 19915793 10.1007/s00726-009-0367-z 1:CAS:528: DC%2BC3cXlt1Omu7w%3D
22. V Peters EW Jansen C Jakobs, et al. 2011 Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration Clin Chim Acta 412 263 267 20971102 10.1016/j.cca.2010.10.016 1:CAS:528:DC%2BC3cXhsF2htb7I
23. E Riedl H Koeppel F Pfister, et al. 2010 N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia Diabetes 59 1984 1990 20460427 10.2337/db09-0868 1:CAS:528:DC%2BC3cXhtVOlsbvE
24. Y Sadzuka T Sonobe 2007 Anserine induced advantage effects on the antitumor activity of doxorubicin Food Chem Toxicol 45 985 989 17240507 10.1016/j.fct.2006.12.004 1:CAS:528:DC%2BD2sXjvFGqtr0%3D
25. S Sauerhöfer G Yuan GS Braun, et al. 2007 L-carnosine, a substrate of carnosinase-1, influences glucose metabolism Diabetes 56 2425 2432 17601992 10.2337/db07-0177
26. J Schönherr 2002 Analysis of products of animal origin in feeds by determination of carnosine and related dipeptides by high-performance liquid chromatography J Agric Food Chem 50 1945 1950 11902938 10.1021/jf0112116
27. Y Suzuki T Nakao H Maemura, et al. 2006 Carnosine and anserine ingestion enhances contribution of nonbicarbonate buffering Med Sci Sports Exerc 38 334 338 16531904 1:CAS:528:DC%2BD28Xit1GqtLY%3D
28. B Szwergold 2005 Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases Biochem Biophys Res Commun 336 36 41 16112643 10.1016/j.bbrc.2005.08.033 1:CAS:528: DC%2BD2MXpvFeht7Y%3D
29. M Tanida J Shen D Kubomura K Nagai 2010 Effects of anserine on the renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats Physiol Res 59 177 185 19537934 1:CAS:528:DC%2BC3cXnvFKmtL0%3D
30. M Teufel V Saudek JP Ledig, et al. 2003 Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase J Biol Chem 278 6251 6531 10.1074/jbc.M209764200